Eiger BioPharmaceuticals Inc - ESG Rating & Company Profile powered by AI
The page is a zero-cost ESG report for Eiger BioPharmaceuticals Inc. If you are employed by Eiger BioPharmaceuticals Inc and you would like to licence your ESG aseessment, please get in touch. The SDG rating for Eiger BioPharmaceuticals Inc indicates its reporting of the UN Sustainable Development Goals.
Eiger BioPharmaceuticals Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 5.4; made up of an environmental score of 5.3, social score of 4.8 and governance score of 6.0.
5.4
Medium ImpactEnvironmental
Social
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| 627 | Ultimovacs ASA | 5.5 | High |
| 627 | United Therapeutics Corp | 5.5 | High |
| 645 | Eiger BioPharmaceuticals Inc | 5.4 | High |
| 645 | Candel Therapeutics Inc | 5.4 | High |
| 645 | Neogenomics Inc | 5.4 | High |
| ... | ... | ... | |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does Eiger BioPharmaceuticals Inc have an accelerator or VC vehicle to help deliver innovation?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose current and historical energy intensity?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc report the average age of the workforce?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc reference operational or capital allocation in relation to climate change?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose its ethnicity pay gap?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose cybersecurity risks?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc offer flexible work?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose the number of employees in R&D functions?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc conduct supply chain audits?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Sign up for free to unlockIs there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc conduct 360 degree staff reviews?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose the individual responsible for D&I?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose current and historical air emissions?
Sign up for free to unlockIs there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Sign up for free to unlockIs executive remuneration linked to climate performance?
Sign up for free to unlockDoes the Board describe its role in the oversight of climate-related risks and opportunities?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose current and / or historical scope 2 emissions?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose water use targets?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc have careers partnerships with academic institutions?
Sign up for free to unlockDid Eiger BioPharmaceuticals Inc have a product recall in the last two years?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose incidents of discrimination?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc allow for Work Councils/Collective Agreements to be formed?
Sign up for free to unlockHas Eiger BioPharmaceuticals Inc issued a profit warning in the past 24 months?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose parental leave metrics?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose climate scenario or pathway analysis?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose current and / or historical scope 1 emissions?
Sign up for free to unlockAre Operating Expesnses linked to emissions reduction?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose the pay ratio of women to men?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc support suppliers with sustainability related research and development?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc reflect climate-related risks in its financial statements?
Sign up for free to unlockIs there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Sign up for free to unlockIs Eiger BioPharmaceuticals Inc involved in embryonic stem cell research?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose GHG and Air Emissions intensity?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose its waste policy?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc report according to TCFD requirements?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose energy use targets?
Sign up for free to unlockDoes Eiger BioPharmaceuticals Inc disclose its Renewable Energy targets?
Subscription requiredAre emissions metrics verified by STBi?
Subscription requiredDoes Eiger BioPharmaceuticals Inc have a policy relating to cyber security?
Sign up for free to unlockHave a different question?
Potential Risks for Eiger BioPharmaceuticals Inc
These potential risks are based on the size, segment and geographies of the company.
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to treat hepatitis delta virus infection. The company's product candidate also include Lambda, which targets type III interferon receptors that has completed Phase II clinical trials; Lonafarnib for the treatment of progeria and progeroid laminopathies; and Avexitide for the treatment of congenital hyperinsulinism, as well as has completed Phase II clinical trials to treat post-bariatric hypoglycemia. Eiger BioPharmaceuticals, Inc. was founded in 2008 and is headquartered in Palo Alto, California.